JP2013501794A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501794A5
JP2013501794A5 JP2012524779A JP2012524779A JP2013501794A5 JP 2013501794 A5 JP2013501794 A5 JP 2013501794A5 JP 2012524779 A JP2012524779 A JP 2012524779A JP 2012524779 A JP2012524779 A JP 2012524779A JP 2013501794 A5 JP2013501794 A5 JP 2013501794A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
age
treatment
group
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2012524779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013501794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/044946 external-priority patent/WO2011019678A1/en
Publication of JP2013501794A publication Critical patent/JP2013501794A/ja
Publication of JP2013501794A5 publication Critical patent/JP2013501794A5/ja
Abandoned legal-status Critical Current

Links

JP2012524779A 2009-08-11 2010-08-10 目の疾患を治療するためのイソチオゾール Abandoned JP2013501794A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
US61/233,047 2009-08-11
PCT/US2010/044946 WO2011019678A1 (en) 2009-08-11 2010-08-10 Isothiozoles for treating conditions of the eye

Publications (2)

Publication Number Publication Date
JP2013501794A JP2013501794A (ja) 2013-01-17
JP2013501794A5 true JP2013501794A5 (https=) 2013-10-03

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012524779A Abandoned JP2013501794A (ja) 2009-08-11 2010-08-10 目の疾患を治療するためのイソチオゾール

Country Status (11)

Country Link
US (1) US20110039900A1 (https=)
EP (1) EP2464351A1 (https=)
JP (1) JP2013501794A (https=)
KR (1) KR20120081585A (https=)
CN (1) CN102695505A (https=)
AU (1) AU2010282698A1 (https=)
BR (1) BR112012003284A8 (https=)
CA (1) CA2770894A1 (https=)
IN (1) IN2012DN01846A (https=)
RU (1) RU2012105453A (https=)
WO (1) WO2011019678A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2863601T3 (es) 2014-09-17 2021-10-11 Panoptica Inc Formulaciones oculares para administración de fármacos y protección del segmento anterior del ojo
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment of neuro-inflammatory diseases
WO2020132045A1 (en) 2018-12-19 2020-06-25 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
MX2007004781A (es) * 2004-10-20 2007-05-11 Applied Research Systems Derivados de 3-arilamino piridina.
EP2068856A2 (en) * 2006-07-25 2009-06-17 Alcon Research, Ltd. Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Similar Documents

Publication Publication Date Title
JP2011518833A5 (https=)
JP2013032389A5 (https=)
JP2015501783A5 (https=)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
MX343620B (es) Forma polimorfica de clorhidrato de pridopidina.
EP4241772A3 (en) Process for the preparation of compounds useful for treating spinal muscular atrophy
JP2013525444A5 (https=)
EA201301181A1 (ru) Триазолопиридины
JP2011105738A5 (https=)
WO2010048332A3 (en) Compounds for treating ophthalmic diseases and disorders
MX349950B (es) Profarmacos de treprostinil enlazados a un portador.
JP2009149903A5 (https=)
EA201270575A1 (ru) Соединения
EA201491028A1 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
JP2014500861A5 (https=)
JP2011527299A5 (https=)
IN2012DN02139A (https=)
JP2013523846A5 (https=)
TN2014000112A1 (en) Ep1 receptor ligands
JP2016540749A5 (https=)
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
UA117154C2 (uk) Антагоністи s1p3
JP2016532632A5 (https=)